Gilead Sciences, Inc.
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada,…
Insiders
Transactions
| Reported Owner(s) | Position Now | Transaction Date | Type | Position Change | Extra | ||
|---|---|---|---|---|---|---|---|
|
$132,373
d
cs
10% Holder
|
12/16/24 |
S
|
8,500 x $91.96 = $781,660.00 |
Footnotes
#1 The transaction reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on August 29, 2024.
|
|||
|
$37,533
d
cs
10% Holder
|
12/13/24 |
M
|
157 x $0 = $0 |
Footnotes
#1 Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
#2 Mandatory tax withholding on vesting of restricted stock units due to retirement eligibility.
|
|||
|
$37,078
d
cs
10% Holder
|
12/13/24 |
F
|
157 x $91.86 = $14,422.02 |
Footnotes
#1 Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
#2 Mandatory tax withholding on vesting of restricted stock units due to retirement eligibility.
|
|||
|
$21,618
d
cs
10% Holder
|
12/10/24 |
M
|
639 x $0 = $0 |
Footnotes
#1 Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
|
|||
|
$21,312
d
cs
10% Holder
|
12/10/24 |
F
|
306 x $92.34 = $28,256.04 |
Footnotes
#1 Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
|
|||
Get PRO Today
With PRO you will unlock 119 more insider transactions for Gilead Sciences, Inc.
Individuals
We summarize earnings call passages, compensations, insider transactions and other information for each individual to get the bigger picture:
- Barton Jacqueline K Director
- Berger Dietmar Chief Medical Officer
- Bluestone Jeffrey Director
- Dickinson Andrew D Chief Financial Officer
- Horning Sandra Director
- Kramer Kelly A. Director
- Lofton Kevin E Director
- Love Ted W Director
- Manwani Harish Director
- Mercier Johanna Chief Commercial Officer
- O'Day Daniel Patrick Chairman & CEO
- Parsey Merdad Chief Medical Officer
- Patterson Sandra SVP, Controllership
- Rodriguez Javier Director
- Telman Deborah H EVP, Corporate Affairs & GC
- Welters Anthony Director
Individuals
We summarize earnings call passages, compensations, insider transactions and other information for each individual to get the bigger picture:
- Barton Jacqueline K Director
- Berger Dietmar Chief Medical Officer
- Bluestone Jeffrey Director
- Dickinson Andrew D Chief Financial Officer
- Horning Sandra Director
- Kramer Kelly A. Director
- Lofton Kevin E Director
- Love Ted W Director
- Manwani Harish Director
- Mercier Johanna Chief Commercial Officer
- O'Day Daniel Patrick Chairman & CEO
- Parsey Merdad Chief Medical Officer
- Patterson Sandra SVP, Controllership
- Rodriguez Javier Director
- Telman Deborah H EVP, Corporate Affairs & GC
- Welters Anthony Director